A Safety Study of ST316 in Participants With Familial Adenomatous Polyposis (FAP).

​ Conditions: Familial Adenomatous Polyposis (FAP)

Interventions: Drug: ST316 IV; Drug: ST316 IV

Sponsors: Sapience Therapeutics

Not yet recruiting Conditions: Familial Adenomatous Polyposis (FAP)
Interventions: Drug: ST316 IV; Drug: ST316 IV
Sponsors: Sapience Therapeutics
Not yet recruiting